Welcome to Exalon

Your partner for high quality eCTDs, regulatory submission services and EVMPD support

Our highly experienced team of regulatory affairs, documentation and IT professionals provides a comprehensive set of services covering all aspects of the electronic drug regulatory affairs business.

We are publishing eCTD submissions for of all types of applications (e.g. medicinal product dossiers, master files) in all regions. Our services include submission hosting, processing of individual submission documents as well as consultancy in all questions of electronic drug regulatory business.

In addition to our electronic publishing services we support the registration of your medicinal products in xEVMPD in acc. to Article 57(2) second subparagraph of Regulation 726/2004.

We provide consulting and training regarding eCTD and xEVMPD requirements and support the implementation of electronic submission and tracking systems in the pharmaceutical industry.

Exalon Blog

  • Elementum pretium dui

    Posted on
    Id hendrerit enim do sodales in lectus eget neque auctor vivamus bibendum gravida aenean. Lacinia eu molestie aliquet ut etiam tortor massa mi donec proin pellentesque quis ultricies egestas. Laoreet nisl posuere rhoncus tortor adipiscing luctus sodales urna ullamcorper odio aliquet in lectus molestie. Turpis porttitor ac porttitor praesent scelerisque tellus iaculis phasellus tellus eleifend….
    READ MORE → Elementum pretium dui
  • Lorem ipsum dolor sit amet pretium imperdiet

    Posted on
    Lorem ipsum dolor sit amet pretium imperdiet consequat risus mi faucibus eros sed semper lacinia. Ullamcorper viverra vivamus nibh justo tortor purus tempus euismod diam interdum enim eleifend quam. Fusce iaculis senectus malesuada ac nullam turpis donec ultrices dolore laoreet libero eiusmod tortor elementum. Sodales netus labore fringilla integer senectus diam ornare pretium elementum orci…
    READ MORE → Lorem ipsum dolor sit amet pretium imperdiet

EMA announces launch of eCTD v4.0 pilot phase III on forward compatibility for EU Centrally Authorised Products https://esubmission.ema.europa.eu/ #eCTD4 #EMA #DrugRegulatory

Final EU eCTD v4.0 Validation Criteria v1.1 out now – fresh from EMA! Rules updated, changes tracked, file naming best practices included. Applicable 15 July 2026.
Who's already testing v4.0 submissions? Drop your thoughts below https://esubmission.ema.europa.eu/
#eCTDv4 #EMA

Mehr laden

eCTD implemen­tation

interactive map

  • AE – United Arab Emirates – GCC
  • AM – Armenia – EAEU “eCTD”
  • AT – Austria
  • AU – Australia
  • BE – Belgium
  • BG – Bulgaria
  • BH – Bahrain – GCC
  • BR – Brazil – planned
  • BY – Belarus – EAEU “eCTD”
  • CA – Canada
  • CH – Switzerland
  • CN – China
  • CY – Cyprus
  • CZ – Czechia
  • DE – Germany
  • DK – Denmark
  • EE – Estonia
  • EG – Egypt – planned
  • ES – Spain
  • FI – Finland
  • FR – France
  • GB – United Kingdom
  • GR – Greece
  • HR – Croatia
  • HU – Hungary
  • IE – Ireland
  • IS – Iceland
  • IT – Italy
  • JO – Jordan
  • JP – Japan
  • KE – Kenya – planned
  • KG – Kyrgyzstan – EAEU “eCTD”
  • KR – South Korea
  • KW – Kuwait – GCC
  • KZ – Kazakhstan – EAEU “eCTD”
  • LI – Liechtenstein
  • LT – Lithuania
  • LU – Luxembourg
  • LV – Latvia
  • MT – Malta
  • NL – Netherlands
  • NO – Norway
  • OM – Oman – GCC
  • PL – Poland
  • PT – Portugal
  • QA – Qatar – GCC
  • RO – Romania
  • RS – Serbia – planned
  • RU – Russia – EAEU “eCTD”
  • SA – Saudi Arabia – GCC
  • SE – Serbia
  • SG – Singapore – planned
  • SI – Slovenia
  • SK – Slovakia
  • TH – Thailand
  • TW – Taiwan
  • US – United States
  • ZA – South Africa